Klippel, Zandra
Inserm · National and Kapodistrian University of Athens · Université de Lille · Centre Hospitalier Universitaire de Lille · Sorbonne Université · Hôpital Saint-Antoine · Istanbul University
2 papers on CoChat
Most cited papers
- Verified
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study
Dimopoulos, M., Quach, H., Mateos, M.-V., Landgren, O., Leleu, X., Siegel, D., Weisel, K., Yang, H., Klippel, Z., Zahlten-Kumeli, A., et al. (2020) · The Lancet
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 430
- Verified
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Facon, T., Dimopoulos, M.-A., Leleu, X. P., Beksac, M., Pour, L., Hájek, R., Liu, Z., Minarik, J., Moreau, P., Romejko-Jarosinska, J., et al. (2024) · New England Journal of Medicine
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 284
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free